Efficacy of a new fractional CO2 laser in the treatment of photodamage and acne scarring.
This study evaluates the efficacy and safety of a novel fractional CO(2) laser device for improving facial rhytids, hyperpigmentation, enlarged pores, skin laxity, and acne scarring. Subjects (n= 15) were treated three to five times at 3-week intervals. Biopsy specimens were used to evaluate healing response and neocollagenesis. Clinical improvement was rated on a quartile rating scale from digital photographs. Subject discomfort during treatment was evaluated on a scale of 0 to 5. Fourteen subjects who completed the study achieved good to excellent improvement in overall appearance, with 60% rated excellent. Improvement in photodamage was good to excellent in 92% of subjects, and reduction in rhytids was good to excellent in 85%. A total of 79% of subjects achieved good to excellent improvement in pore sizes and skin laxity. Subject discomfort during treatment was 3.0 +/- 0.7. Erythema persisted for 2-3 days, and subjects resumed normal activities 1-2 days after the procedure. Histological slides after a single treatment showed new collagen formation. The SmartSkin fractional CO(2) system (Cynosure, Inc., Westford, MA, USA) provides significant improvement for the treatment of facial wrinkles, hyperpigmentation, pore size, and skin laxity associated with photodamage.
Katz
Bruce
B
Department of Dermatology, Mt. Sinai School of Medicine, JuvaSkin & Laser Center, New York, New York, USA. brukatz@gmail.com
D000152:Acne Vulgaris / Q000150:complications*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002921:Cicatrix / Q000209:etiology / Q000601:surgery*; D003094:Collagen / Q000096:biosynthesis / Q000097:blood; D003357:Cosmetic Techniques; D005145:Face; D005260:Female; D006801:Humans; D017495:Hyperpigmentation / Q000601:surgery; D054020:Lasers, Gas / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D017060:Patient Satisfaction; D015595:Skin Aging; D016896:Treatment Outcome
D003094:Collagen